Next Article in Journal
Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Scaffolds for the Development of Novel Anticancer Candidates Targeting SIRT2 and EGFR
Next Article in Special Issue
PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-Analysis
Previous Article in Journal
Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions
 
 
Systematic Review

Article Versions Notes

Pharmaceuticals 2025, 18(5), 732; https://doi.org/10.3390/ph18050732
Action Date Notes Link
article xml file uploaded 16 May 2025 12:42 CEST Original file -
article xml uploaded. 16 May 2025 12:42 CEST Update -
article pdf uploaded. 16 May 2025 12:42 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/732/pdf-vor
article supplementary file uploaded. 16 May 2025 12:42 CEST - https://www.mdpi.com/1424-8247/18/5/732#supplementary
article html file updated 16 May 2025 12:47 CEST Original file -
article xml file uploaded 20 May 2025 09:08 CEST Update -
article xml uploaded. 20 May 2025 09:08 CEST Update https://www.mdpi.com/1424-8247/18/5/732/xml
article pdf uploaded. 20 May 2025 09:08 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/732/pdf
article html file updated 20 May 2025 09:10 CEST Update -
article html file updated 25 June 2025 04:42 CEST Update https://www.mdpi.com/1424-8247/18/5/732/html
Back to TopTop